Millennium Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-361,222
| Closed | -$7.28M | – | 7725 |
|
|
2021
Q3 | $7.28M | Buy |
361,222
+25,736
| +8% | +$711K | ﹤0.01% | 2434 |
|
|
2021
Q2 | $12.5M | Sell |
335,486
-88,403
| -21% | -$2.71M | 0.01% | 1651 |
|
|
2021
Q1 | $10.8M | Buy |
423,889
+56,106
| +15% | +$1.43M | 0.01% | 1681 |
|
|
2020
Q4 | $8.1M | Buy |
367,783
+124,919
| +51% | +$2.75M | 0.01% | 1978 |
|
|
2020
Q3 | $4.37K | Sell |
242,864
-197,992
| -45% | -$4.1M | 0.01% | 1965 |
|
|
2020
Q2 | $11.2M | Sell |
440,856
-177,229
| -29% | -$3.82M | 0.02% | 1138 |
|
|
2020
Q1 | $11.4M | Sell |
618,085
-7,825
| -1% | -$152K | 0.03% | 772 |
|
|
2019
Q4 | $13.8M | Buy |
625,910
+250,270
| +67% | +$5.04M | 0.02% | 1108 |
|
|
2019
Q3 | $5.39M | Sell |
375,640
-388,754
| -51% | -$5.56M | 0.01% | 1738 |
|
|
2019
Q2 | $12M | Buy |
764,394
+635,517
| +493% | +$8.64M | 0.02% | 1114 |
|
|
2019
Q1 | $1.89M | Buy |
128,877
+5,454
| +4% | +$62.7K | ﹤0.01% | 2446 |
|
|
2018
Q4 | $1.32M | Buy |
123,423
+19,009
| +18% | +$250K | ﹤0.01% | 2448 |
|
|
2018
Q3 | $1.59M | Buy |
104,414
+25,649
| +33% | +$373K | ﹤0.01% | 2598 |
|
|
2018
Q2 | $965K | Sell |
78,765
-328,765
| -81% | -$4.13M | ﹤0.01% | 2857 |
|
|
2018
Q1 | $3.9M | Buy |
407,530
+340,623
| +509% | +$3.67M | 0.01% | 1955 |
|
|
2017
Q4 | $604K | Buy |
66,907
+39,348
| +143% | +$289K | ﹤0.01% | 3000 |
|
|
2017
Q3 | $158K | Buy |
+27,559
| New | +$100K | ﹤0.01% | 3304 |
|
|
2017
Q1 | – | Sell |
-39,140
| Closed | -$113K | – | 3976 |
|
|
2016
Q4 | $113K | Sell |
39,140
-5,182
| -12% | -$18.4K | ﹤0.01% | 3178 |
|
|
2016
Q3 | $261K | Sell |
44,322
-8,371
| -16% | -$29.3K | ﹤0.01% | 2873 |
|
|
2016
Q2 | $158K | Buy |
52,693
+32,629
| +163% | +$134K | ﹤0.01% | 2953 |
|
|
2016
Q1 | $108K | Sell |
20,064
-272,496
| -93% | -$1.72M | ﹤0.01% | 3075 |
|
|
2015
Q4 | $3.47M | Sell |
292,560
-54,484
| -16% | -$623K | 0.01% | 1607 |
|
|
2015
Q3 | $2.85M | Sell |
347,044
-43,420
| -11% | -$501K | 0.01% | 1680 |
|
|
2015
Q2 | $5.45M | Buy |
+390,464
| New | +$7.16M | 0.01% | 1344 |
|
Other funds holding DRNA
Millennium Management's DRNA Position: Q4 2021 in Review
Millennium Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 361,222 shares — an estimated $7.28M sold.
Millennium Management first reported a position in DRNA in Q2 2015 and held it in 24 quarters. The position peaked at $13.8M in Q4 2019. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Millennium Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Millennium Management sold 361,222 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $7.28M.
- Millennium Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2015 and held it in 24 quarters.
- Millennium Management's Dicerna Pharmaceuticals, Inc. position peaked at $13.8M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.